Resumo
Definición
Anamnesis y examen
Principales factores de diagnóstico
- presença de fatores de risco
- início inesperado
- apreensão e preocupação
- comportamento de evitação
- taquicardia
- resultado positivo para rastreamento do pânico da Avaliação de Transtornos Mentais na Atenção Primária (PRIME-MD)
- escala de gravidade do transtorno de pânico (EGTP)
- pontuação de corte do GAD-7 ≥10
Otros factores de diagnóstico
- palpitações, dor e desconforto torácicos
- náuseas e dor abdominal
- tontura
- anormalidades das percepções
- sintomas respiratórios
- dependência de pistas indicativas de segurança
- parestesias
- tremor muscular
- sudorese
- desmaios
- calafrios ou fogachos
Factores de riesgo
- história em parentes de primeiro grau
- idade 18 a 39 anos
- sexo feminino
- etnia branca e índios norte-americanos
- eventos vitais importantes
- transtornos comórbidos
- fatores psicológicos
- asma e variabilidade respiratória
- tabagismo
- consumo de cafeína
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- avaliação clínica
Pruebas diagnósticas que deben considerarse
- eletrocardiograma (ECG)
- glicose sanguínea
- testes da função tireoidiana
- perfil metabólico
- análise toxicológica
Algoritmo de tratamiento
ataque de pânico agudo
transtorno de pânico
ataques de pânico sem transtorno de pânico
Colaboradores
Autores
Craig N. Sawchuk, PhD

Professor
Department of Psychiatry and Psychology
Mayo Clinic
Rochester
MN
Divulgaciones
CNS declares that he has no competing interests.
Jason P. Veitengruber, MD

Associate Professor
Department of Psychiatry and Behavioral Sciences
University of Washington School of Medicine
Seattle
WA
Divulgaciones
JPV declares that he has no competing interests.
Revisores por pares
Tanveer A. Padder, MD
Chairman
Department of Psychiatry
Trinity School of Medicine
Warner Robins
GA
Divulgaciones
TAP declares that he has no competing interests.
Paul Blenkiron, BM BCh, MA
Consultant Psychiatrist
Leeds and York Partnership NHS Foundation Trust
Bootham Park Hospital
York
UK
Divulgaciones
PB declares that he has no competing interests.
Philip J. Cowen, MD, FRCPsych, FMedSci
Professor of Psychopharmacology
Warneford Hospital
Oxford
UK
Divulgaciones
PJC declares that he has no competing interests.
Toshiaki A. Furukawa, MD, PhD
Professor and Chair
Department of Psychiatry and Cognitive-Behavioral Medicine
Graduate School of Medical Sciences
Nagoya City University
Nagoya
Japan
Divulgaciones
TAF has received research funds and speaking fees from Astellas, Dai-Nippon, Sumitomo, Eli Lilly, GlaxoSmithKline, Janssen, Meiji, Otsuka, Schering-Plough, and Yoshitomi. He was on a research advisory board for Meiji and Mochida, and is currently on research advisory boards for Sekisui chemicals and Takeda Science Foundation. He has received royalties from Igaku-Shion and Seiwa-Shoten Publishers. The Japanese Ministry of Education, Science, and Technology and the Japanese Ministry of Health, Labor, and Welfare have also funded his research.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision, (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
Andrews G, Bell C, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry. 2018;52(12):1109-172.Texto completo
Penninx BW, Pine DS, Holmes EA, et al. Anxiety disorders. Lancet. 2021 Mar 6;397(10277):914-27.Texto completo Resumen
Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14 Suppl 1:S1.Texto completo Resumen
Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA. 2010 May 19;303(19):1921-8. Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Agorafobia
- Fobias específicas
- Transtorno da ansiedade social
Más DiferencialesGuías de práctica clínica
- Diagnostic and statistical manual of mental disorders: 5th edition, text revision (DSM-5-TR)
- Generalised anxiety disorder and panic disorder in adults: management
Más Guías de práctica clínicaFolletos para el paciente
Ansiedade: quais são as opções de tratamento?
Ansiedade: o que é?
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad